ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1573

Vascular Monosodium Urate Crystal Deposition in Gout: A Dual-energy CT and Microscopy Study of Cadaveric Donors

Nicola Dalbeth1, Mariam Alhilali1, Peter Riordan1, Ravi Narang1, Ashika Chhana1, Sue McGlashan1, Anthony Doyle1 and MARIANO ANDRES2, 1University of Auckland, Auckland, New Zealand, 2Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain

Meeting: ACR Convergence 2021

Keywords: Cardiovascular, Computed tomography (CT), gout, urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II (1565–1583)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Cardiovascular disease is a common comorbidity in people with gout. A hypothesized link between cardiovascular disease and gout is the deposition of monosodium urate (MSU) crystals in atherosclerotic plaque. Recent dual-energy CT (DECT) studies have reported that color-coded material consistent with MSU crystal deposition is present in calcified vessels of patients with gout. However, it is unclear whether these appearances represent true MSU crystal deposition or artifact during live imaging. The aim of this study was to examine whether MSU crystal deposition is present in the great vessels of cadaveric donors with gout by DECT or microscopic analysis.

Methods: Six cadaveric donors with a documented history of gout (two with visible tophi) were studied. Vascular tissue was dissected from the arch of the aorta through to the descending aorta at the level of the diaphragm, and included the proximal few centimeters of the brachiocephalic, common carotids, and subclavian arteries. Vascular tissue from each donor was scanned by DECT (SOMATOM Definition Flash, Siemens Medical, Erlangen, Germany) and analyzed for urate deposition on a Siemens workstation using proprietary gout software (syngo MMWP VE 36A 2009, Siemens Medical). After scanning, 100µl of phosphate buffered saline was injected into the vessel wall at ten standardized sites across each sample, and aspirated fluid was analyzed by polarizing light microscopy. Positive control tissue included the foot joints of cadaveric donors with tophaceous gout analyzed by DECT and microscopy using the same protocols, as well as synthesized MSU crystals as controls at the time of microscopic analysis.

Results: DECT scanning of the cadaveric vascular tissue showed calcification in all samples, but no evidence of MSU crystal deposition (Figure 1). In contrast, urate deposition was clearly evident in the positive control tophaceous joint tissue by DECT. Microscopic analysis demonstrated plate-like cholesterol crystals from vascular tissue from five of the six donors (mean (SD) 3.2 (1.9) sites/donor, Figure 2). A single negatively birefringent needle shaped crystal was visualized from one of the 60 standardized sites analyzed, with no MSU crystals evident at any other site. In contrast, numerous negatively birefringent needle shaped crystals were present in aspirates from positive control tophaceous joint tissue.

Conclusion: This analysis has not demonstrated extensive MSU crystal deposition in vascular tissue of cadaveric donors with gout by DECT or polarizing light microscopy.

Figure 1. Dual energy CT. Left panel. Representative DECT image of cadaveric vascular tissue demonstrating vascular calcification in blue, but no urate deposition (color-coded green). Right panel. Representative DECT image of positive control cadaveric tophaceous joint tissue demonstrating urate deposition (color-coded green) within tophaceous deposits. Nail artifact is also evident.

Figure 2. Polarizing light microscopy. Left panel. Representative polarizing microscopy image from cadaveric vascular tissue demonstrating plate-like cholesterol crystals, but no needle-shaped negatively birefringent crystals. Scale bar 10µm. Right panel. Representative polarizing microscopy image from positive control cadaveric tophaceous joint tissue demonstrating numerous needle-shaped negatively birefringent crystals. Scale bar 10µm.


Disclosures: N. Dalbeth, AstraZeneca, 2, JW Pharmaceutical Corporation, 2, PK Med, 2, Horizon, 2, Selecta, 2, Dyve Biosciences, 2, Arthrosi, 2, Amgen, 5; M. Alhilali, None; P. Riordan, None; R. Narang, None; A. Chhana, None; S. McGlashan, None; A. Doyle, None; M. ANDRES, Menarini, 6, Grunenthal, 5, 6.

To cite this abstract in AMA style:

Dalbeth N, Alhilali M, Riordan P, Narang R, Chhana A, McGlashan S, Doyle A, ANDRES M. Vascular Monosodium Urate Crystal Deposition in Gout: A Dual-energy CT and Microscopy Study of Cadaveric Donors [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/vascular-monosodium-urate-crystal-deposition-in-gout-a-dual-energy-ct-and-microscopy-study-of-cadaveric-donors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascular-monosodium-urate-crystal-deposition-in-gout-a-dual-energy-ct-and-microscopy-study-of-cadaveric-donors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology